Claritev ROA 2019-2024 | CTEV
Claritev ROA - Return on Assets Historical Data | |||
---|---|---|---|
Date | TTM Net Income | Total Assets | Return on Assets |
2024-12-31 | $-1.65B | $5.15B | -29.16% |
2024-09-30 | $-1.54B | $5.32B | -25.24% |
2024-06-30 | $-1.17B | $5.74B | -17.94% |
2024-03-31 | $-0.63B | $6.37B | -9.17% |
2023-12-31 | $-0.09B | $6.97B | -1.28% |
2023-09-30 | $-0.71B | $7.06B | -9.87% |
2023-06-30 | $-0.67B | $7.14B | -8.91% |
2023-03-31 | $-0.62B | $7.22B | -7.95% |
2022-12-31 | $-0.57B | $7.37B | -7.14% |
2022-09-30 | $0.10B | $8.19B | 1.25% |
2022-06-30 | $0.16B | $8.22B | 1.95% |
2022-03-31 | $0.10B | $8.28B | 1.21% |
2021-12-31 | $0.10B | $8.22B | 1.23% |
2021-09-30 | $-0.10B | $8.28B | -1.15% |
2021-06-30 | $-0.46B | $8.34B | -7.08% |
2021-03-31 | $-0.47B | $8.36B | -9.99% |
2020-12-31 | $-0.52B | $8.28B | -17.92% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.325B | $0.931B |
Claritev Corporation is a healthcare technology, data and insights company. Claritev Corporation, formerly known as MultiPlan, is based in NEW YORK. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Veeva Systems (VEEV) | United States | $35.134B | 48.53 |
Tempus AI (TEM) | United States | $6.966B | 0.00 |
Hims & Hers Health (HIMS) | United States | $6.050B | 97.25 |
Inspire Medical Systems (INSP) | United States | $4.470B | 86.83 |
IRhythm Technologies (IRTC) | United States | $3.223B | 0.00 |
Privia Health (PRVA) | United States | $2.873B | 215.27 |
Schrodinger (SDGR) | United States | $1.881B | 0.00 |
Clover Health Investments (CLOV) | United States | $1.839B | 0.00 |
Enovis (ENOV) | United States | $1.825B | 11.29 |
Omnicell (OMCL) | United States | $1.418B | 30.59 |
Phreesia (PHR) | United States | $1.409B | 0.00 |
Azenta (AZTA) | United States | $1.154B | 53.72 |
10x Genomics (TXG) | United States | $0.918B | 0.00 |
Butterfly Network (BFLY) | United States | $0.568B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.551B | 0.00 |
Talkspace (TALK) | United States | $0.450B | 267.00 |
Veradigm (MDRX) | United States | $0.449B | 0.00 |
Standard BioTools (LAB) | United States | $0.440B | 0.00 |
TruBridge (TBRG) | United States | $0.363B | 0.00 |
Health Catalyst (HCAT) | United States | $0.270B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.206B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.189B | 0.00 |
Pulmonx (LUNG) | United States | $0.182B | 0.00 |
American Well (AMWL) | United States | $0.109B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.100B | 0.00 |
Retrieve Medical Holdings (RMHI) | United States | $0.082B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.076B | 0.00 |
P3 Health Partners (PIII) | United States | $0.066B | 0.00 |
111 (YI) | China | $0.064B | 0.00 |
CareCloud (CCLD) | United States | $0.060B | 2.58 |
HeartBeam (BEAT) | United States | $0.055B | 0.00 |
Outset Medical (OM) | United States | $0.040B | 0.00 |
Zepp Health (ZEPP) | China | $0.039B | 0.00 |
Zhongchao (ZCMD) | China | $0.030B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
MSP Recovery (MSPR) | United States | $0.014B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.010B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
Precipio (PRPO) | United States | $0.009B | 0.00 |
Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
Movano (MOVE) | United States | $0.007B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.004B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
Syra Health (SYRA) | United States | $0.001B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |